Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Global Injectable Drug Delivery Market to Grow at a CAGR of 12% by 2023: Growth in Pharmaceutical & Biotechnology Industry to Drive Growth - Research and Markets

Research and Markets
Posted on: 04 Aug 17

The "Global Injectable Drug Delivery Market Insights, Opportunity Analysis, Market Shares and Forecast, 2017 - 2023" report has been added to Research and Markets' offering.

The global inject able drug delivery market is expected to rise at a CAGR of 12% during the forecast period 2016-2023. Growth in pharmaceutical and biotechnology industry is contributing to the growth of the global inject able drug delivery market. However, infection associated with needle stick injury is the factor restraining the growth of the global inject able drug delivery market during the forecast period.

Geographically, North America accounted for the largest market share in terms of revenue for inject able drug delivery market in 2016 and the region is expected to dominate the market during the forecast period followed by Europe. The dominance of the region is attributed to technologically advanced healthcare facilities in the countries of the region. However, Asia Pacific is expected to be the fastest growing region for inject able drug delivery market during the forecast period. The highest growth in the region is observed due to enhancing healthcare infrastructure and prevalence of chronic diseases in the region.

The growth in global inject able drug delivery market is also influenced by the presence of major players such as Baxter International (U.S.), Schott AG (Germany), Terumo Corporation (U.S.), Hospira Inc. (U.S.), Sanofi SA (France) etc. The market players adopt some crucial strategies such as product launches, partnerships, mergers & acquisitions gain competitive advantage.

Companies Mentioned:

  • Antares Pharma Inc. (U.S.)
  • Baxter International (U.S.)
  • Becton Dickinson And Company (U.S.)
  • Eli Lilly And Company (U.S.)
  • Gerresheimer Ag (Germany)
  • Hospira Inc. (U.S.)
  • Nono Nordisk (Denmark)
  • Pfizer (U.S.)
  • Sanofi Sa (France)
  • Scandinavian Health Ltd. (Taiwan)
  • Schott Ag (Germany)
  • Terumo Corporation (Japan)
  • Terumo Corporation (U.S.)
  • Unilife Corporation (U.S.)
  • Zogenix Inc. (U.S.)

Key Topics Covered:

1. Introduction

2. Market Overview

3. Market Determinants

4. Market Segmentation

5. Competitive Landscape

6. Geographical Analysis

7. Company Profiles

For more information about this report visit

View source version on

Business Wire

Last updated on: 04/08/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.